1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine D3 receptor

Details for Australian Patent Application No. 2008320814 (hide)

Owner Abbott GmbH & Co. KG

Inventors Lange, Udo; Bespalov, Anton; Turner, Sean Colm; Drescher, Karla; Braje, Wilfried; Geneste, Herve; Jongen-Relo, Ana Lucia; Haupt, Andreas; Unger, Liliane

Agent Spruson & Ferguson

Pub. Number AU-A-2008320814

PCT Pub. Number WO2009/056625

Priority 07119927.7 02.11.07 EP

Filing date 31 October 2008

Wipo publication date 7 May 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/056625 Priority application(s): WO2009/056625

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320815-Use of halogenated phthalocyanines

2008320812-Pressure sensor assembly and method of using the assembly